Třeška V, Skalický T, Liška V, Fichtl J, Brůha J, Skála M, Šebek J, Duras P
Rozhl Chir. 2017 Spring;96(4):151-155.
Liver hemangiomas are the most common benign tumors of the liver. Most are asymptomatic and are found accidentally by ultrasonography, computed tomography or magnetic resonance imaging of the abdomen. Liver hemangiomas usually do not need any treatment. Nevertheless, symptomatic, giant hemangiomas can be indicated for surgery, embolization or thermoablation. The aim of this study was to define based on our own experience and on the literature when and what treatment option should be indicated in patients suffering from liver hemangioma.
In the last five years 37 patients with giant hemangiomas indicated for invasive treatment were enrolled in the study. The mean size of the hemangiomas was 67 mm (45-221 mm). Multiple hemangiomas were present in 11 (29.7%) patients. Enucleation was performed in 15 (40.5%), non-anatomical liver resection in three, (8.1%), left lobectomy in one (2.7%) and exploratory laparotomy for a suspected malignant liver tumor in two (5.4%) patients where malignancy was excluded based on contrast enhanced peroperative ultrasonography. Percutaneous transarterial embolization (TAE) was performed in 16 (43.2%) patients.
There was zero mortality. A hematoma in the resection line, with spontaneous regression was present in two (10.5%) patients after the surgery. The post-embolization syndrome was presented in three (16.7%) patients after TAE. Progression of the hemangioma was seen in three (28.8%), regression in six (37.5%) patients, and in seven (43.8%) patients the finding remained stable in the interval of 14 years after TAE.
Conservative approach is can be applied in most liver hemangiomas, especially in small, asymptomatic lesions. Liver surgery is indicated in giant symptomatic or growing hemangiomas with the diameter over 10 cm or in non-specific lesions where the preoperative diagnosis is uncertain. We recommend enucleation as the method of choice, or non-anatomic liver resection. TAE is indicated in high-risk patients and can be repeated if the hemangioma progresses. The use of other methods such as radiofrequency ablation needs to be verified in large clinical studies.Key words: liver hemangiomas - treatment methods.
肝血管瘤是肝脏最常见的良性肿瘤。大多数无症状,通过腹部超声、计算机断层扫描或磁共振成像偶然发现。肝血管瘤通常无需任何治疗。然而,有症状的巨大血管瘤可考虑手术、栓塞或热消融治疗。本研究的目的是根据我们自己的经验和文献,确定肝血管瘤患者何时以及应选择何种治疗方案。
在过去五年中,37例有创治疗指征的巨大血管瘤患者纳入本研究。血管瘤的平均大小为67毫米(45 - 221毫米)。11例(29.7%)患者存在多发血管瘤。15例(40.5%)患者行摘除术,3例(8.1%)行非解剖性肝切除术,1例(2.7%)行左叶切除术,2例(5.4%)患者因怀疑肝恶性肿瘤行剖腹探查术,术中根据术中超声造影排除恶性肿瘤。16例(43.2%)患者行经皮经动脉栓塞术(TAE)。
无死亡病例。2例(10.5%)患者术后在切除线处出现血肿,后自行消退。3例(16.7%)患者TAE术后出现栓塞后综合征。3例(28.8%)患者血管瘤进展,6例(37.5%)患者血管瘤消退,7例(43.8%)患者在TAE术后14年期间病情稳定。
大多数肝血管瘤可采用保守治疗方法,尤其是小型无症状病变。有症状的巨大血管瘤或直径超过10厘米的生长性血管瘤,或术前诊断不确定的非特异性病变,建议行肝脏手术。我们推荐摘除术作为首选方法,或行非解剖性肝切除术。TAE适用于高危患者,若血管瘤进展可重复进行。其他方法如射频消融的应用需要在大型临床研究中得到验证。关键词:肝血管瘤 - 治疗方法